Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue Therapeutics' subsidiary Baergic…

UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding phase 1 data for the bladder cancer drug didn’t reach…

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. Now, the study has to…

Eli Lilly has linked its amylin agonist eloralintide to up to 20.1% weight loss at Week 48, encouraging the drugmaker to…

In a groundbreaking exploration of the telencephalic GABAergic landscape, van Velthoven and colleagues unveil a sophisticated map of neuronal subclasses…

In a groundbreaking study that could reshape the future of biofuel production, researchers have unveiled the biotechnological potential of an…

In the relentless pursuit of scalable and robust quantum computing platforms, superconducting qubits have emerged as front-runners, yet their coherence…

In the realm of ethnobotany, the exploration of traditional medicinal practices uncovers a wealth of knowledge instilled in various cultures…

In the ever-evolving landscape of healthcare, the resilience of nurses emerges as a pivotal component influencing not only their professional…